Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Zoetis (ZTS)

NYSE: ZTS · Veterinary Pharmaceuticals · Parsippany, NJ

Our rating: Positive

Positive reaffirmed at $79.40, high conviction, November 6, 2026.

Breaks if: The Positive call rests on the slowdown being cyclical and the franchise remaining competitively intact. It would be proved wrong if revenue growth turns negative — two consecutive quarters of year-over-year declines reported by mid-2027 — or if free cash flow margin falls below 18% for two straight quarters by that same point. Either outcome would signal structural pressure on the franchise rather than a soft patch, at which point the low multiple becomes a symptom of deterioration, not an opportunity. On the upside, the call would escalate if revenue re-accelerates to 6% or above on a trailing-twelve-month basis within the next four quarters and the FCF-to-net-income gap narrows, confirming the slowdown was transitory.

Key figures

Market value$32.1B
Revenue, last 12 months$9.5B
Net income, last 12 months$2.5B
Free cash flow, last 12 months$2.2B
Price to earnings12.8×
Free cash flow yield7.0%
Dividend yield2.7%
Operating marginn/a
Return on equity57.6%
Beta to the S&P 5000.57
Volatility, annualized31.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$2.4B−1.3%$1.44$717M
June 30, 2026$2.5B−0.2%$1.65$538M
March 31, 2026$2.3B2.9%$1.42$291M
December 31, 2025$2.4B2.4%$1.42$689M
September 30, 2025$2.4B1.4%$1.63$798M
June 30, 2025$2.5B4.8%$1.63$459M
March 31, 2025$2.2B0.4%$1.34$337M
December 31, 2024$2.3B4.7%$1.29$689M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

13 ledger entries and 21 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.